Edwards Lifesciences Corp (NYSE: EW) is -11.83% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $96.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $69.36 in the last trading session, with the day’s loss setting it -2.13%.
Currently trading at $67.23, the stock is -2.19% and -7.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.35 million and changing -3.07% at the moment leaves the stock -17.45% off its SMA200. EW registered -8.16% loss for a year compared to 6-month loss of -27.59%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.45% gain in the last 1 month and extending the period to 3 months gives it a -22.61%, and is 0.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.19% over the week and 3.18% over the month.
Edwards Lifesciences Corp (EW) has around 19800 employees, a market worth around $40.50B and $6.00B in sales. Current P/E ratio is 27.67 and Fwd P/E is 24.46. Profit margin for the company is 24.55%. Distance from 52-week low is 14.08% and -30.06% from its 52-week high. The company has generated returns on investments over the last 12 months (18.17%).
with sales reaching $1.56B over the same period.The EPS is expected to grow by 6.96% this year, but quarterly earnings will post 4.20% year-over-year. Quarterly sales are estimated to grow 5.40% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1878.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 86.48% of the company’s shares. The shares outstanding are 601.10M, and float is at 592.02M with Short Float at 1.06%. Institutions hold 85.70% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.9056% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $4.71 billion to account for 8.4733 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3233% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3812 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by BOBO DONALD E JR, the company’s CVP,Strategy/Corp Development. SEC filings show that BOBO DONALD E JR sold 5,000 shares of the company’s common stock on Sep 11 ’24 at a price of $66.77 per share for a total of $0.33 million. Following the sale, the insider now owns 46936.0 shares.
Edwards Lifesciences Corp disclosed in a document filed with the SEC on Aug 20 ’24 that Chopra Daveen (CVP, TMTT) sold a total of 1,250 shares of the company’s common stock. The trade occurred on Aug 20 ’24 and was made at $69.95 per share for $87438.0. Following the transaction, the insider now directly holds 29333.0 shares of the EW stock.
Still, SEC filings show that on Aug 20 ’24, Chopra Daveen (Officer) Proposed Sale 1,250 shares at an average price of $69.95 for $87438.0. The insider now directly holds shares of Edwards Lifesciences Corp (EW).
